Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-066395

Director acquired 4,584,571 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moin Andrew · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-24 Exercise or conversion : show line 1 in the form +4,584,571 4,584,571 I

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-24 Exercise or conversion : show line 2 in the form Series A-1 Convertible Preferred Stock −31,269 $1,000.00 $31,269,000 0 I
2023-11-24 Exercise or conversion : show line 3 in the form Series A-2 Convertible Preferred Stock +28,380 $1,000.00 $28,380,000 28,380 I
Loading xslF345X05/ownership.xml…